SMBC Group, Fujitsu, and SoftBank Agree to Business Alliance in Health and Medical Field to Build a Domestic Healthcare Platform for Sustainable Healthcare

SMBC Group, Fujitsu, and SoftBank have partnered to build a domestic healthcare platform that utilizes medical and health data to extend healthy lifespans and curb medical costs in Japan.
Business PartnershipNQ 95/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 19, 2026 at 22:00
  • 🔍 Collected: May 19, 2026 at 13:31
  • 🤖 AI Analyzed: May 21, 2026 at 15:25 (49h 53m after Collected)
SMBC Group, Fujitsu Limited, and SoftBank Corp. have signed a basic agreement for a business alliance in the health and medical field to ensure the sustainability of Japan's healthcare system. The partnership will establish a domestic healthcare platform to securely manage and utilize medical data with patient consent. It will also offer a user app with an AI agent that combines medical and personal health data to provide personalized support, from daily wellness to medical treatment. The initiative aims to promote health, encourage behavioral changes, and ultimately contribute to curbing future medical expenses by an estimated 5 trillion yen.

FAQ

Which companies are involved in this healthcare partnership?

The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.

What is the main objective of this alliance?

The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.

What will the new healthcare platform consist of?

It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.

What are the roles of each company in this partnership?

SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.

What are the long-term goals of this initiative?

The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.

Back to Newsroom (51)